Anifrolumab
AstraZeneca
['anifro', 'lupus']
#eular2023 #op0051 4-year pooled analyses of 3 x anifrolumab rcts in #lupus (inc. lte) showed: - lldas was attained earlier &amp; more cumulative time was spent in lldas in anifrolumab compared to placebo groups assuring longer-term data *sorry photos weren t permitted 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏